Literature DB >> 10923636

Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass.

N Lahlou1, K Clement, J C Carel, C Vaisse, C Lotton, Y Le Bihan, A Basdevant, Y Lebouc, P Froguel, M Roger, B Guy-Grand.   

Abstract

Leptin resistance and obesity have been related to mutations of the leptin receptor gene in rodents and, recently, in a consanguineous family. The latter mutation results in a receptor lacking transmembrane and intracellular domains. Homozygous and heterozygous individuals with this mutation had serum leptin levels higher than expected, given their BMIs: 600, 670, and 526 ng/ml and 145, 362, 294, 240, and 212 ng/ml, respectively. Their serum leptin was fractionated by gel filtration: >80% was present as a high-molecular size complex vs. 7.5% in the nonmutated sister. Western blot analysis showed a band at 146 kDa reacting specifically with an antibody directed against the leptin receptor ectodomain. In 10 obese control subjects, as in the mutated patients, free leptin levels correlated with BMI (r = 0.70, P = 0.0011) and reflected fat mass, regardless of leptin receptor functioning. In the patients, bound leptin levels correlated with BMI (r = 0.99, P = 0.0002) and were related to the number of mutated alleles. These data demonstrate that the truncated receptor is secreted into blood and binds the majority of serum leptin, markedly increasing bound and total leptin. Free serum leptin was similarly correlated with BMI in the mutated and nonmutated obese individuals, providing evidence that the relationship between BMI and circulating free leptin is preserved in this family. This finding suggests that the leptin receptor itself may not be specifically involved in the control of leptin secretion, and it supports the concept of relative resistance to leptin in common obesity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923636     DOI: 10.2337/diabetes.49.8.1347

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Serum levels of leptin receptor in patients with systemic sclerosis.

Authors:  Yukimi Ohyoshi; Takamitsu Makino; Masatoshi Jinnin; Wakana Nakayama; Satoshi Fukushima; Yuji Inoue; Hironobu Ihn
Journal:  Intractable Rare Dis Res       Date:  2013-05

3.  Gene variants and binge eating as predictors of comorbidity and outcome of treatment in severe obesity.

Authors:  Natascha Potoczna; Ruth Branson; John G Kral; Grazyna Piec; Rudolf Steffen; Thomas Ricklin; Margret R Hoehe; Klaus-Ulrich Lentes; Fritz F Horber
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

4.  Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease.

Authors:  Xiao-Dong Huang; Yan Fan; Hen Zhang; Ping Wang; Jing-Ping Yuan; Ming-Jie Li; Xi-Yan Zhan
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

Review 5.  Lessons from extreme human obesity: monogenic disorders.

Authors:  Sayali A Ranadive; Christian Vaisse
Journal:  Endocrinol Metab Clin North Am       Date:  2008-09       Impact factor: 4.741

6.  Human soluble leptin receptor concentration in healthy offspring of hypertensive parents.

Authors:  Dimitris P Papadopoulos; Thomas K Makris; Maria Poulakou; Urania G Papazachou; Antonios N Hatzizacharias; Despina N Perrea; Vassilios E Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

7.  Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor.

Authors:  I Sadaf Farooqi; Teresia Wangensteen; Stephan Collins; Wendy Kimber; Giuseppe Matarese; Julia M Keogh; Emma Lank; Bill Bottomley; Judith Lopez-Fernandez; Ivan Ferraz-Amaro; Mehul T Dattani; Oya Ercan; Anne Grethe Myhre; Lars Retterstol; Richard Stanhope; Julie A Edge; Sheila McKenzie; Nader Lessan; Maryam Ghodsi; Veronica De Rosa; Francesco Perna; Silvia Fontana; Inês Barroso; Dag E Undlien; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2007-01-18       Impact factor: 91.245

Review 8.  Leptin and Obesity: Role and Clinical Implication.

Authors:  Milan Obradovic; Emina Sudar-Milovanovic; Sanja Soskic; Magbubah Essack; Swati Arya; Alan J Stewart; Takashi Gojobori; Esma R Isenovic
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

9.  Leptin, soluble leptin receptor, and transforming growth factor-beta1 levels in minimal change nephrotic syndrome.

Authors:  Necla Buyan; Ozan Ozkaya; Aysun Bideci; Oğuz Söylemezoğlu; Peyami Cinaz; Sevim Gönen; Süleyman Kalman; Sevcan Bakkaloğlu; Enver Hasanoğlu
Journal:  Pediatr Nephrol       Date:  2003-07-29       Impact factor: 3.714

10.  Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity.

Authors:  Richard Gill; Yee Him Cheung; Yufeng Shen; Patricia Lanzano; Nazrat M Mirza; Svetlana Ten; Noel K Maclaren; Roja Motaghedi; Joan C Han; Jack A Yanovski; Rudolph L Leibel; Wendy K Chung
Journal:  Obesity (Silver Spring)       Date:  2013-10-15       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.